Chitosan Oligosaccharides Attenuate Ocular Inflammation in Rats with Experimental Autoimmune Anterior Uveitis

الملخص EN

We investigated the protective effects and mechanisms of chitosan oligosaccharides (COS) on experimental autoimmune anterior uveitis (EAAU) in rats.

EAAU was induced in Lewis rats by footpad and intraperitoneal injections of melanin-associated antigen.

The rats received intraperitoneal injections of low-dose (5 mg/kg) or high-dose (10 mg/kg) COS or PBS daily after the immunization.

The effects of COS were evaluated by determining the clinical scores and the morphology of the iris/ciliary body (ICB).

The expression of inflammatory mediators was evaluated using western blot, immunofluorescence, and ELISA.

Treatment with COS significantly attenuated the clinical scores and the leukocyte infiltration in the ICB in a dose-dependent manner.

COS effectively reduced the expression of inflammatory mediators (TNF-α, iNOS, MCP-1, RANTES, fractalkine, and ICAM-1).

Moreover, COS decreased the IκB degradation and p65 presence in the ICB, which resulted in the inhibition of NF-κB/DNA binding activity.

In an in vitro study, sensitized spleen-derived lymphocytes of the COS-treated group showed less chemotaxis toward their aqueous humor and decreased secretion of the above inflammatory mediators in the culture media.

COS treated EAAU by inhibiting the activation of NF-κB and reducing the expression of inflammatory mediators.

COS might be a potential treatment for acute anterior uveitis.